Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2020-08-19 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −11,100 355,800
2020-08-19 BENZENO SHARON Chief Business Development Off Option exercise +416 $6.27 $3K 416
2020-08-19 BENZENO SHARON Chief Business Development Off Sale −416 $41.57 $17K 0
2020-08-19 BENZENO SHARON Chief Business Development Off Option exercise · Stock Option (Right to Buy) −416 3,334
2020-08-17 LO FRANCIS Chief People Officer Option exercise +2,000 $7.80 $16K 2,000
2020-08-17 LO FRANCIS Chief People Officer Sale −1,439 $39.11 $56K 561
2020-08-17 LO FRANCIS Chief People Officer Sale −561 $40.01 $22K 0
2020-08-17 LO FRANCIS Chief People Officer Option exercise · Stock Option (Right To Buy) −2,000 194,000
2020-08-17 HERSHBERG ROBERT Director Option exercise +2,000 $0.45 $900 2,000
2020-08-17 HERSHBERG ROBERT Director Sale −1,439 $39.13 $56K 561
2020-08-17 HERSHBERG ROBERT Director Sale −561 $40.04 $22K 0
2020-08-17 HERSHBERG ROBERT Director Option exercise · Stock Option (Right to Buy) −2,000 67,000
2020-08-17 Cohen Chad M Chief Financial Officer Option exercise +10,000 $6.32 $63K 11,000
2020-08-17 Cohen Chad M Chief Financial Officer Sale −10,000 $40.00 $400K 1,000
2020-08-17 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right To Buy) −10,000 610,000
2020-08-13 BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ Grant or award · Stock Option (Right to Buy) +20,000 20,000
2020-08-12 ROBINS CHAD M CEO and Chairman Option exercise +16,680 $0.33 $6K 1,794,860
2020-08-12 ROBINS CHAD M CEO and Chairman Sale −901 $36.80 $33K 1,793,959
2020-08-12 ROBINS CHAD M CEO and Chairman Sale −6,774 $37.50 $254K 1,787,185
2020-08-12 ROBINS CHAD M CEO and Chairman Sale +9,005 $38.43 $346K 1,778,180

Page 94 of 120 · 2,386 trades